Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein by Paleologou, Katerina E. et al.
Phosphorylation at Ser-129 but Not the Phosphomimics
S129E/D Inhibits the Fibrillation of -Synuclein*□S
Received for publication, January 29, 2008, and in revised form, March 13, 2008 Published, JBC Papers in Press,March 14, 2008, DOI 10.1074/jbc.M800747200
Katerina E. Paleologou‡, Adrian W. Schmid‡, Carla C. Rospigliosi§, Hai-Young Kim¶, Gonzalo R. Lamberto,
Ross A. Fredenburg**, Peter T. Lansbury, Jr.**, Claudio O. Fernandez, David Eliezer§1, Markus Zweckstetter¶,
and Hilal A. Lashuel‡2
From the ‡Laboratory of Molecular Neurobiology and Neuroproteomics, BrainMind Institute, Ecole Polytechnique Federale de
Lausanne, CH-1015 Lausanne, Switzerland, §Department of Biochemistry and Program in Structural Biology, Weill Cornell Medical
College, New York, New York 10021, ¶Department of NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry,
Deutsche Forschungsgemeinschaft Research Center for theMolecular Physiology of the Brain, 37077 Go¨ttingen, Germany,
Instituto de Biologı´a Molecular y Celular de Rosario, Consejo Nacional de Investigaciones Cientı´ficas y Te´cnicas, Universidad
Nacional de Rosario, Suipacha 531, S2002LRK Rosario, Argentina, and **Harvard Center for Neurodegeneration and Repair, Center
for Neurologic Diseases, Brigham andWomen’s Hospital and Department of Neurology, HarvardMedical School,
Cambridge, Massachusetts 02139
-Synuclein (-syn) phosphorylation at serine 129 is charac-
teristic of Parkinson disease (PD) and related -synulceinopa-
thies. However, whether phosphorylation promotes or inhibits
-syn aggregation and neurotoxicity in vivo remains unknown.
This understanding is critical for elucidating the role of-syn in
the pathogenesis of PD and for development of therapeutic
strategies for PD. To better understand the structural and
molecular consequences of Ser-129 phosphorylation, we com-
pared the biochemical, structural, andmembrane binding prop-
erties of wild type-syn to those of the phosphorylationmimics
(S129E, S129D) as well as of in vitro phosphorylated-syn using
a battery of biophysical techniques. Our results demonstrate
that phosphorylation at Ser-129 increases the conformational
flexibility of -syn and inhibits its fibrillogenesis in vitro but
does not perturb its membrane-bound conformation. In addi-
tion, we show that the phosphorylation mimics (S129E/D) do
not reproduce the effect of phosphorylation on the structural
and aggregation properties of -syn in vitro. Our findings have
significant implications for current strategies to elucidate the
role of phosphorylation in modulating protein structure and
function in health and disease and provide novel insight into the
underlyingmechanisms that govern-syn aggregation and tox-
icity in PD and related -synulceinopathies.
Mounting evidence from pathologic, genetic, animal model,
biochemical, and biophysical studies support the hypothesis
that -synuclein (-syn)3 plays a central role in the pathogene-
sis of Parkinson disease (PD) and several other neurodegenera-
tive diseases, including Alzheimer disease, multiple system
atrophy, dementia with Lewy bodies, Down syndrome, and
neurodegeneration with brain iron accumulation, collectively
referred to as “synucleinopathies” (1). Although the exact func-
tion of -syn remains poorly understood, it is thought to play a
role in regulating dopamine neurotransmission (2), vesicular
trafficking (3, 4), andmodulating synaptic function and plastic-
ity (5, 6). Increasing evidence suggests that phosphorylation
may be an important regulator of -syn oligomerization, fibril-
logenesis, Lewy body (LB) formation, and neurotoxicity in vivo
(7). Immunohistochemical and biochemical studies suggest
that themajority of-synwithin LBs frompatientswith PD and
related synucleinopathies (8–12) is phosphorylated at Ser-129
(Ser(P)-129). Proteinaceous inclusions formed in cellular and
animalmodels overexpressingWT ormutant -syn can also be
stained with an antibody against Ser(P)-129.
A study by Fujiwara et al. (8) reported that in vitro phospho-
rylated -syn (at Ser-129, using casein kinase II (CK2)) forms
fibrils more readily than unmodified -syn. Phosphorylation at
Ser-129 was also reported to promote the formation of cyto-
plasmic inclusions in some cell culturemodels of synucleinopa-
thies (13). Together, these findings suggested that phosphoryl-
ation at Ser-129 plays an important role in modulating -syn
aggregation, LB formation, and toxicity in vivo. However, in
vivo studies by Feany and co-worker (7) suggest a lack of corre-
lation between phosphorylation at Ser-129 and the level of
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-synfibrillation. Overexpression of the phosphomimic S129D
or coexpression of WT -syn and G protein-coupled receptor
kinase 2 (Gprk2), which phosphorylates -syn specifically at
Ser-129, in the Drosophila model of PD results in increased
-syn toxicity without an increase in the number of -syn
inclusions (comparedwith overexpression ofWT-syn). Inter-
estingly, overexpression of S129A results in a significant
increase (4) in the number of inclusions and suppression of
dopaminergic neuronal loss produced by expression of WT
human -syn.
We considered that a rigorous examination and comparison
of the biochemical and biophysical properties of phosphoryla-
tion mimicking mutants (S129A and S129E/D), andWT -syn
may clarify the observations described above as well as the
molecular mechanisms by which phosphorylation at Ser-129
may modulate -syn aggregation and toxicity in vivo. In addi-
tion to the phosphorylation mimics, we prepared, purified, and
characterized the in vitro phosphorylated Ser(P)-129 form of
-syn. To better understand the role of the phosphate group in
modulating -syn aggregation and membrane binding proper-
ties, we compared the structural, oligomerization, fibrillation,
and membrane binding properties of WT -syn to those of the
phosphorylation mimics (S129E, S129D) as well as the purified
in vitro phosphorylated form of -syn using NMR, circular
dichroism (CD), size exclusion chromatography (SEC), SDS-
PAGE, thioflavin T (ThT), and transmission electron micros-
copy (TEM). Together our results demonstrate that phospho-
rylation at Ser-129 inhibits rather than promotes -syn fibril
formation in vitro. Equally important is our finding that the
phosphorylationmimics (S129E/D) do not reproduce the effect
of phosphorylation at this site on -syn structure and aggrega-
tion properties in vitro. These findings have significant impli-
cations for modeling synulceinopathies in vivo and our under-
standing of the role of -syn in the pathogenesis of PD and
related disorders.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of -Syn Variants—
The S129E, S129D, S129A, and S87A -syn mutants were
generated using site-directed mutagenesis employing com-
plementary internal mutagenic primers and two-step PCR.
All constructed sequences were confirmed by DNA sequenc-
ing. All proteins used in these studies were expressed as previ-
ously described (14). For theNMRstudies, expression and puri-
fication of unlabeled and 15N-labeled -syn were performed as
described previously (15, 16). To enable attachment of a spin
label, a single cysteine was introduced into -syn at position 18
(A18C). The nitroxide spin label chosen for reaction with the
cysteine-containingmutant was 1-oxy-2, 2, 5, 5-tetramethyl-D-
pyrroline-3-methyl)-methanethiosulfonate (MTSL, Toronto
Research Chemicals, Toronto, Ontario, Canada). MTSL has
already been shown to efficiently react with -syn cysteine
mutants, and the reaction was carried out as described previ-
ously (17).
In Vitro Phosphorylation of Recombinant -Syn—WT or
mutant -syn was phosphorylated by CK1 (New England Bio-
labs) at a concentration of 1.44 mg/ml (100 M) unless other-
wise stated. The reaction was carried out in the presence of
1.09 mM ATP (Sigma), 1 reaction solution supplied with
the enzyme, and 1200 units of CK1/145 g of -syn. The
phosphorylation reaction was incubated at 30 °C for the
stated time points, and the reaction was stopped with EDTA
disodium salt (5 mM final concentration) (Axon Lab). The
progress of the reaction was monitored by reverse phase
HPLC and mass spectrometry.
Fibrillation Studies—Toprobe the effect of CK1 phosphoryl-
ation on the aggregation of -syn, WT -syn was phosphoryl-
ated for 24 h at 30 °C, and the reaction was stopped with EDTA
disodium salt before the samples were subjected to fibrillation
conditions at 37 °C with continuous shaking for the indicated
time points. The unphosphorylated controls were subjected to
the same conditions, but CK1 was not added. For fibrillation
studies the proteins were dissolved in 20 mM Bis-Tris propane
(Aldrich), 100 mM lithium chloride (Aldrich), pH 7.4, at a con-
centration of 70M, and fibril formationwasmonitored byThT
using an Analyst Fluorescence instrument (LJL Biosystems) as
described previously (18).
Sedimentation and Gel-filtration Separation of Monomeric
-Syn from Fibrillar Material—The degree of -syn oligomer-
ization was measured by determining the amount of soluble
monomeric and oligomeric -syn in solution at the indicated
time points during the aggregation process. 75-l aliquots
withdrawn at the indicated time points from amain-syn sam-
ple incubating at 37 °C were centrifuged at 18,000  g for 30
min at 4 °C to remove any fibrils. The supernatant was then
separated from the pelleted fibrils, and 30 l were injected on
an analytical Waters 2795 system equipped with a Waters 996
photodiode array detector and using an analytic Superdex 200
PC 3.2/30 column (Amersham Biosciences). The supernatant
was also run on SDS-PAGE gels and stained with Coomassie
Blue staining to verify the stability of the protein (see below).
Gel Electrophoresis (SDS-PAGE) and Immunoblotting—
-Syn samples were diluted in loading buffer and separated on
12% SDS 1-mm gels. Gels were stained with Simply Blue safe
stain (Invitrogen) or silver staining (Invitrogen) according to
the manufacturer’s instructions. For dot blot analysis, the pro-
teins were deposited onto nitrocellulose membrane (Omnilab
SA), and the membrane was blocked with Odyssey blocking
buffer (Li-COR Biosciences GmbH) diluted 1:3 in PBS (Sigma)
for 1 h at room temperature. The membrane was probed with
the primary antibody (mousemonoclonal anti--syn (121-125)
(211) at a dilution of 1:500 (Santa Cruz Biotechnology) or
mouse anti--syn (15-123) at a dilution of 1:1000 (BD Trans-
duction) ormousemonoclonal anti-phosphorylated -syn Ser-
129 at a dilution of 1:5000 (Wako) or rabbit polyclonal anti-
phosphorylated -syn Ser-87 at a dilution of 1:100) at room
temperature for 1–2 h. After 4 PBST (PBS, 0.01% (v/v) Tween
20 (Fluka)) washes, the membrane was incubated with the sec-
ondary antibody (i.e. goat anti-mouse ALEXA Fluor 680) pro-
tected from light at room temperature for 1 h. The immunoblot
was finally washed 4 times with PBST and 3 times with PBS and
scanned in a Li-COR scanner at a wavelength of 700 nm.
TEM—For TEM studies, WT or mutant -syn samples were
deposited on Formvar-coated 200 mesh copper grids (Electron
Microscopy Sciences) at a concentration of 25 M. Grids were
washedwith 2 drops ofwater and stainedwith 2 drops of freshly
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prepared 0.75% (w/v) uranyl acetate (Electron Microscopy Sci-
ences). Specimens were inspected on a Philip CIME 12 electron
microscope, operated at 80 kV. Digitized photographs were
recorded with a slow scan CCD camera (Gatan, Model 679).
Reverse Phase HPLC—Monitoring the phosphorylation reac-
tion and purification of the various phosphorylated species of
-syn (i.e. monophosphorylated or diphosphorylated -syn)
was accomplished using reverse phase HPLC on aWaters 2795
instrument equipped with a Waters 996 photodiode array
detector and using an analytical (4.6-mm inner diameter) or
semi-preparative (10-mm inner diameter) C4 or C18-RP col-
umn (Vydac). A 35–50% linear gradient over (flow rate  1
ml/min) (0.09% (v/v) trifluoroacetic acid (solutionA), 90% (v/v)
acetonitrile aqueous solution (solution B)) was applied, and the
signal wasmonitored at 214 nm. In the case of the semi-prepar-
ative reverse phase HPLC, a 40–60% linear gradient over (flow
rate 5 ml/min) solution A, solution B was applied.
Preparation of Large Unilamellar Vesicles and Small Unila-
mellar Vesicles and -Syn-Liposome Complexes—1-Palmitoyl-
2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium
salt) (POPG) (Avanti Polar Lipids Inc.) was purchased in chlo-
roform which was removed by evaporation and lyophilization.
The residual phospholipid was hydrated with 50 mM HEPES
(Fluka), 150 mM NaCl (Fluka), pH 7.4, solution, giving rise to a
phospholipid suspension of 10 mg/ml. To increase the effi-
ciency of large unilamellar vesicles formation, 10 cycles of
freezing in dry ice and thawing at 37 °C water bath were carried
out. Small unilamellar vesicles were prepared by extrusion
through a 100-nm polycarbonate membrane (Avestin Inc.)
according to the manufacturer’s instructions. The small unila-
mellar vesicles were stored at 4 °C and used within 3–5 days.
The appropriate amount and volume of-syn in PBS or sodium
phosphate, pH 7.5, was mixed with the appropriate volume of
POPG to generate a mass ratio of -syn:POPG of 1:20. The
-syn-liposome complex was incubated for 2 h at room tem-
perature before CD spectroscopy.
Circular Dichroism—The average secondary structure of
monomeric -syn was determined by CD spectroscopy using a
Jasco 810 Spectrometer. The FarUV-CD spectra (190–250 nm,
integration time of 2 s for 0.2 nm) were collected at room tem-
perature in a 1-mm path length quartz cuvette containing 0.1
mg/ml of -syn in PBS or sodium phosphate buffer.
Matrix-assisted Laser Desorption Ionization Time-of-flight
(MALDI-TOF)Mass Spectrometry—For two layer sample prep-
aration, MALDI matrices and calibrants were from Sigma/
Fluka (Schnelldorf, Germany), trifluoroacetic acid was from
Pierce, and sinapinic acid and 2,5-dihydroxybenzoic acid were
fromFluka. Cytochrome c and apomyoglobinwere fromSigma.
2-l aliquots of each collected peaks were reserved for the
MALDI analysis. A two-layer sample preparation was selected
for the molecular weight analysis. Two matrix solutions were
prepared; a saturated solution of sinapinic acid in methanol
(matrix solution 1) and a 14 mg/ml sinapinic acid solution in
0.1% trifluoroacetic acid, acetonitrile (1/1) (matrix solution 2).
A thin matrix layer was first generated on the mirror-polished
target using a gel loader tip with matrix solution 1. 1 l of
sample was mixed with 1 l of sinapinic acid matrix solution,
and 0.8l of this mixture was deposited on top of the thin layer
and allowed to air dry. Samples were deposited twice and ana-
lyzed with a 4700MALDI-TOF/TOF instrument (Applied Bio-
systems). 8000 laser shots were typically summed by random
sampling of the surface to generate the spectra that were cali-
brated externally on the pseudomolecular peak of cytochrome
c, and apomyoglobin was prepared with the same matrix and
deposited close to the samples.
NMR—NMR samples of free -syn contained0.1 mM 15N-
labeled WT or mutant -syn in 90% H2O, 10% D2O, 50 mM
phosphate buffer at pH 7.4, 100 mM NaCl. NMR experiments
were acquired on Bruker Avance 600 and 700MHzNMR spec-
trometers. The temperature was set to 15 °C. At higher temper-
atures, NMR resonances particularly in the N-terminal domain
were broadened. NMR data were processed and analyzed using
NMRPipe (19) and Sparky 3 (T. D. Goddard and D. G. Kneller,
SPARKY 3, University of California, San Francisco) and NMR-
View (20). Spectra were referenced indirectly to sodium 2,2-di-
methyl-2-silapentane-5-sulfonate and ammonia using the
known chemical shift of water. Tentative assignments for the
spectra of mutant and phosphorylated proteins were obtained
by transferring each previously assigned cross-peak in the
1H,15N heteronuclear single quantum coherence (HSQC) spec-
trumof theWTprotein to the nearest unassigned cross-peak in
each new spectrum. Subsequently, they were verified by three-
dimensional HNHA and three-dimensional NOE-HSQC spec-
tra. Normalized weighted average chemical shift differences for
amide 1H and 15N chemical shifts were calculated according to
av  [(2HN  2N/25)/2]1/2. 3J(HN,H) scalar couplings
were measured in WT -syn, phosphorylated S87A -syn, and
S129D -syn using intensity modulated HSQC experiments.
Pulse field gradient NMR experiments were acquired on unla-
beledWT and mutant -syn (200 M) dissolved in 99.9% D2O,
50 mM phosphate buffer, pH 7.4, and containing dioxane (20
mM) as an internal radius standard and viscosity probe (21).
Twenty one-dimensional 1H spectra were collected as a
function of gradient amplitude employing the PG-SLED
sequence (21, 22). Each experiment was repeated at least
twice. The gradient strength was increased from 1.69 to
33.72 Gauss/cm in a linear manner. Each 1H spectrum com-
prised 32 scans plus 16 steady-state scans. 16,000 complex
points were acquired with a spectral width of 6000 Hz. Sig-
nals corresponding to the aliphatic region of the 1H spectra
(3.3–0.5 ppm) were integrated, and diffusion data (signal inten-
sity versus gradient strength) were fitted to Gaussian functions
using XWINNMR (Bruker Instruments, Karlsruhe, Germany).
Stokes radii of -syn were calculated from the apparent diffusion
coefficients of -syn and dioxane and the known Stokes radius of
dioxane (22). Errors in stokes radii estimated from repeat meas-
urements are about 0.3 Å. For WT and phosphorylated S87A
-syn, paramagnetic relaxation enhancement profiles were
derived from the measurement of peak intensity ratios between
two 1H,15NHSQC spectra in the presence (Ipar) and absence (Idia)
of the nitroxide radical.
NMR for SDS Micelle-bound -Syn—NMR experiments on
SDSmicelle-bound -syn were performed on samples contain-
ing 120 M -syn. Lyophilized S87A, either unphosphorylated
or phosphorylated, was dissolved in sample buffer (100 mM
NaCl, 10mMNa2HPO4, pH 7.4, in 90%, 10%H2O,D2O)with 40
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mM SDS. Two-dimensional 1H,15N HSQC spectra were
recorded on a Varian INOVA spectrometer operating at a 1H
resonance frequency of 600MHz and a sample temperature of
40 °C for all samples.
RESULTS
Generation of Ser(P)-129 and the Phosphomimics S129E/D—
The structural and electrostatic similarities between Glu/Asp
and phospho-Ser suggest that this type of substitution repre-
sents a reasonable approach to mimic constitutive phosphoryl-
ation at a specific Ser residue (Fig. 1A). The phosphatemoiety at
pH 7 exists predominately in the fully deprotonated state,
resulting in a net charge of2, in contrast to the single negative
charge contributed by Glu/Asp. To determine whether a sub-
stitution of Ser-129 by an acidic residue is sufficient to mimic
the effect of phosphorylation, we prepared mutants in which
Ser-129 was replaced by Glu (S129E) or Asp (S129D). To pro-
videmechanistic insight into the in vivo studies performedwith
the phosphorylation mimics, the S129A variant was also pre-
pared. The S129E, S129D, and S129A mutations were intro-
duced within the human cDNA sequence of SNCA by two-step
PCR mutagenesis, and the mutant proteins were expressed in
Escherichia coli and purified to greater than 95% homogeneity,
as verified by SDS-PAGE and mass spectrometry.
To determine whether mutation of Ser-129 into a charged
residue is sufficient to reproduce the effect of phosphorylation
on the structural and aggregation properties of -syn in vitro,
we prepared the Ser(P)-129 -syn using CK1. We found that
CK1 phosphorylates -syn more efficiently than casein kinase
II (supplemental Fig. 2). To block CK1-mediated phosphoryla-
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tion at Ser-87, the S87A mutant of -syn was expressed, puri-
fied, and phosphorylated in vitro to generate S87A/Ser(P)-129
-syn (supplemental Fig. 3). To verify that phosphorylation by
CK1 occurs at Ser-129, we made use of the anti-phospho-Ser-
129 antibody (supplemental Fig. 4). Ser(P)-129 can be detected
as early as the first 3 h of incubation (data not shown) and
increases with time and increasing CK1 concentration.
-Syn Is Disordered Independent of Phosphorylation—To
elucidate the consequences of phosphorylation on the structure
and dynamics of monomeric -syn, we performed a series of
CDmeasurements and high resolutionNMR studies. NMR res-
onances in 1H,15N HSQC spectra of WT and S87A -syn,
unphosphorylated and phosphorylated, were recorded at 15 °C.
For all proteins, the resonances were sharp and showed only a
limited dispersion of chemical shifts, reflecting a high degree of
backbone mobility (Fig. 1). Chemical shifts in WT and S87A
-syn in the unphosphorylated formwere highly similar except
in direct vicinity of the mutation site (supplemental Fig. 4).
Upon phosphorylation ofWT -syn by CK1, the resonances of
Ser-87 and Ser-129 were strongly attenuated at the position
seen in the HSQC of the unphosphorylated protein. At the
same time, new signals appeared in the region in which reso-
nances of phosphorylated amino acids are usually found (Figs.
1, C andD, and supplemental Fig. 1). Three-dimensional NMR
spectra assigned the new signals to Ser-87 and Ser-129. For
S87A -syn, phosphorylation at Ser-87 was blocked such that
only the resonance of Ser-129 was attenuated at its original
position and appeared at its phosphorylated position (Fig. 1D).
Other chemical shift changes induced by phosphorylationwere
generally small. Detailed analysis, however, showed that the
chemical shifts of residues down to residue 90 were influenced
by phosphorylation of Ser-129 in S87A-syn. In addition, weak
chemical shift changes were observed for the 60 N-terminal
residues (Fig. 2C) in S87A-syn, in agreementwith recent stud-
ies (23).
3J(HN,H) scalar couplings are highly sensitive to the dihe-
dral angles of the protein backbone. We measured 3J(HN,H)
couplings in WT -syn and phosphorylated S87A -syn.
3J(HN,H) couplings were mostly close to their random coil
values and were very similar for unphosphorylated WT and
phosphorylated Ser-87-syn (data not shown), indicating
that phosphorylation has no apparent effect on the second-
ary structure of -syn. Far UV-CD spectra of unphosphoryl-
ated WT, S129E, S129D, S129A, and S87A -syn and phos-
phorylated WT and S87A -syn were virtually identical and
consistent with a predominantly random coil structure (Figs.
1B and 3).
Phosphorylation Expands the Ensemble of Conformations
Populated by -Syn—Pulse field gradient NMR experiments
allow accurate determination of the diffusion coefficient of a
molecule. From the diffusion coefficient, a hydrodynamic
radius Rh can be calculated that provides an estimation of the
overall dimensions of a biomolecule. For WT -syn, we deter-
mined a hydrodynamic radius of 28.2 Å (Fig. 2A). Upon the
addition of 8 M urea, it increased to 36.4 Å. For S87A -syn, the
corresponding values were 28.1 and 36.2 Å, respectively. If
-synwere a true random coil, a hydrodynamic radius of 36.9 Å
would be expected. When WT -syn was phosphorylated, its
hydrodynamic radius increased by 7.1 to 35.3 Å (Fig. 2A). Sim-
ilarly, phosphorylation of S87A -syn at Ser-129 increased Rh
by 6.6 to 34.7 Å (Fig. 2A). The addition of 8 M urea to phospho-
rylated S87A -syn only slightly further increased the Rh value
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to 35.6 Å, indicating that phosphorylation extends the ensem-
ble of conformations populated by -syn close to its fully ran-
dom coil-like dimensions.
Phosphorylation Disrupts Transient Intramolecular Long-
range Interactions—To probe the effect of phosphorylation
on transient long-range interactions, we measured paramag-
netic relaxation enhancement of NMR resonances. The
interactions between a specifically attached paramagnetic
nitroxide radical and nearby (less than25 Å) protons cause
broadening of their NMR signals because of an increase in
transverse relaxation rate (24). This effect has an r6
dependence on the electron-proton distance and, thus,
allows themeasurement of long-range distances between the
spin label and the affected amide protons in proteins (25).
Because the primary sequence of -syn lacks cysteine,
Ala-18 was mutated into a cysteine to provide an attachment
point for the nitroxide radical MTSL. Neither the mere
introduction of the mutation nor the addition of the MTSL
radical modified the hydrodynamic radius or altered the
time course of aggregation for -syn (17). Fig. 2B compares
the paramagnetic relaxation enhancement profile observed
for unphosphorylated WT and phosphorylated S87A -syn.
In unphosphorylated WT -syn, the profile of intensity ratios
showed a broad paramagnetic effect extending to residue 60
and long-range interactions with C-terminal residues 115–140,
in agreement with previousmeasurements (17). In phosphoryl-
ated S87A -syn, the paramagnetic broadening was largely
restricted to the vicinity of the spin label; signal intensities
ratios for residues 45–60 and for C-terminal residues 120–135
approached values close to one.
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To probe the influence of phosphorylation at Ser-129 on
backbone dynamics, we measured 15N spin relaxation times in
WT and S87A -syn. For most of the backbone amides of
unphosphorylated WT and S87A -syn, steady-state hetero-
nuclear 1H,15NNOEswere below0.3 (supplemental Fig. 7) (15).
Residues 68–80 and 90–97 showed 1H,15NNOEvalues slightly
below average, as previously noted (15). Phosphorylation at
Ser-129 did not induce strong changes in theNOE profile, indi-
cating that pico-to-nanosecond motions of the backbone of
-syn were largely unaffected. Similarly, 15N R1 relaxation
rates that are sensitive tomotions of the backbone occurring on
the micro- to millisecond time scale were largely unaffected by
phosphorylation (data not shown).
S129E/D Do Not Reproduce the Structural Consequences of
Phosphorylation—To evaluate if mutation into a charged resi-
due can mimic the effect of phosphorylation on the conforma-
tion of -syn, we characterized monomeric S129D and S129E
-syn by NMR spectroscopy. The 1H,15N HSQC spectra of
S129D/E -syn was highly similar to that observed for the WT
protein. Chemical shift changes were restricted to the direct
vicinity of the mutation site, and 3J(HN,H) were largely
unchanged (Fig. 2D and supplemental Fig. 6). Using pulse field
gradient NMR experiments, we determined hydrodynamic
radii of 28.3 and 27.8 Å for S129D and S129E -syn (Fig. 2A),
respectively, values very similar to WT protein (Rh  28.2 Å)
but significantly smaller than that observed for phosphorylated
-syn (Rh  35.3 Å). Thus, mutation of Ser-129 into aspartate
or glutamate does not disrupt the long-range interactions that
stabilize WT -syn.
Phosphorylation at Ser-129 Does Not Alter the Structure of
Micelle-bound -Syn—To investigate potential effects of Ser-
129 phosphorylation on the structure of membrane-bound
-syn, NMR 1H,15N HSQC spectra of SDS micelle-bound Ser-
129-phosphorylated S87A -syn were compared with equiva-
lent spectra of unphosphorylated protein (Fig. 3, A and B). The
conformation of the micelle-bound protein is thought to effec-
tively mimic that of the membrane-bound form of the protein
(26). Significant chemical shift changes were observed only
near the site of phosphorylation, indicating that Ser-129 phos-
phorylation does not lead to large scale structural changes of
this conformation of the protein (Fig. 3B). In the SDS micelle-
bound state, no long range interactions occur between the
C-terminal and the lipid binding N-terminal domain (26–28),
and thus, no long range effects of Ser-129 phosphorylation are
expected. There is some evidence, however, that membrane
binding subtly influences the conformation of the C-terminal
tail of -syn (28, 29), and a potential perturbation of such an
effect by Ser-129 phosphorylation cannot be excluded based on
these two-dimensional NMR spectra alone.
-Syn is known to undergo a random coil to -helical trans-
formation upon binding to phospholipids. To determine the
effect of phosphorylation at Ser-129 on -syn-lipid interac-
tions, we examined the secondary structure of the purified
monophosphorylated S87A (S87A/Ser(P)-129) in the absence
(Fig. 3C) and presence (Fig. 3D) of phospholipids by CD. In all
cases we observed that phosphorylation does not perturb the
overall conformation of S87A (Fig. 3C) and its ability to adopt
-helical conformations uponbinding to synthetic vesicles (Fig.
3D). Detailed studies are currently under way to accurately
quantify the effect of phosphorylation onmembrane binding by
multiple methods.
S129E Exhibits Similar in Vitro Aggregation Properties as the
WT—To determine the effect of the phospho-mimicking
mutations on the aggregation properties of-syn,we compared
the aggregation propensity of S129E and S129A to that of the
WT protein as a function of time using the ThT binding assay
(Fig. 4A) and TEM (Fig. 4B). In a few experiments, the S129E
variant formed slightly more fibrils than WT protein (Fig. 4B),
but these differences are not statistically significant, and in
other experiments there were no differences in amyloid forma-
tion between the two proteins (WT and S129E). In contrast, we
consistently observed that the S129A fibrillates more rapidly
and forms significantly more fibrils than both the WT and the
phosphorylation mimic, S129E. Both S129A and S129E -syn
formed classical amyloid-like fibrils with morphological fea-
tures similar to that of WT -syn (Fig. 4B).
CK1-mediated Phosphorylation Inhibits -Syn Aggregation—
To investigate the effect of in vitro phosphorylation on -syn
fibril formation, WT -syn was co-incubated with CK1 in the
appropriate reaction buffer at 30 °C for 24 h, after which the
samples were transferred to 37 °C, and fibril formation was
monitored by ThT and TEM and compared with control sam-
ples that were subjected to the same experimental conditions in
the absence of the kinase. We consistently observed that CK1-
mediated phosphorylation significantly inhibits-syn fibril for-
mation, even after 48 h of incubation under agitating conditions
as discerned from the ThT (Fig. 5A) and TEM studies (Fig. 5B).
To verify the ThT and TEM results, we also determined the
amount of soluble -syn species at each time point using SEC
by monitoring the area of the peak corresponding to the mon-
omer. Fig. 5C shows that the amount of monomeric -syn in
samples subjected to CK1 phosphorylation remains unchanged
even after 72 h of incubation under fibril formation conditions,
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protein, but S129A forms significantly more fibrils than WT. A, ThT fluo-
rescence was monitored at indicated time points from samples of 100 M
solutions of WT, S129A, and S129E -syn incubated at 37 °C. The error bars
represent the S.D. of four independent experiments. B, TEM images of WT,
S129A, and S129E -syn after 48 h of aggregation (scale bar, 0.20 m).
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whereas the amount of monomeric unphosphorylated -syn
decreased with time, consistent with the TEM and ThT results.
In all samples, we did not observe any accumulation of stable
soluble oligomers that can be separated by SEC, although we
cannot rule out the possibility of oligomer dissociation in the
column.
Phosphorylation at Ser-129 Is Sufficient to Inhibit the Aggre-
gation of -Syn—Previous studies showed that CK1 phospho-
rylates -syn at Ser-87and Ser-129 (30, 31). To determine the
relative contribution of phosphorylation at Ser-129 to the CK1-
induced inhibition of -syn fibril formation, we examined the
effect of CK1-mediated phosphorylation on the fibrillation of
S87A mutant of -syn. Prephosphorylation of S87A with CK1
results in significant inhibition of -syn fibrillation relative to
the unphosphorylated forms of the protein. After 72 h of incu-
bation under agitation conditions, S87A formed significant
amount of amyloid fibrils, whereas the prephosphorylated form
of S87A (S87A/Ser(P)-129) showed predominantly soluble
-syn species (Fig. 5, A and B). Consistent with the TEM and
ThT results, the amount of monomeric prephosphorylated
S87A (S87A/Ser(P)-129) remained unchanged during the
course of the aggregation experi-
ment (72 h), whereas the amount
of monomeric unphosphorylated
S87A decreased significantly with
time (Fig. 5C).
To further demonstrate that
inhibition of -syn fibrillogenesis
is due to phosphorylation at Ser-
129, we purified the phosphoryla-
ted form of S87A (S87A/Ser(P)-
129) (supplemental Fig. 3) and
compared its aggregation proper-
ties to that of S87A andWT -syn.
When purified WT, S87A and
S87A/Ser(P)-129 -syn were sub-
jected to aggregation conditions at
37 °C with continuous agitation,
and S87A/Ser(P)-129 did not form
any fibrils and remained in a pre-
dominantly monomeric state even
after 96 h of incubation, whereas
the unphosphorylated S87A and
WT -syn exhibited high levels of
fibrillation as demonstrated by the
increased ThT fluorescence (Fig.
5D) and the significant decrease in
levels of monomeric species with
time (SEC) (Fig. 5C) and detection
of fibrillar structures by TEM (Fig.
5E). However, longer incubations
(10 days) of S87A/Ser(P)-129
resulted in the formation of ThT-
fluorescent aggregates that aremor-
phologically distinct from those
formed by unphosphorylated S87A
andWT -syn (supplemental Fig. 8).
S87A/Ser(P)-129 Inhibits the
Fibrillation of S87A in a Dose-dependent Manner—Given that
only 5% of -syn is thought to be phosphorylated at Ser(P)-
129 under physiological conditions (32), we sought to deter-
mine whether the two forms (Ser-129 and Ser(P)-129) of S87A
-syn interact and the consequences of such interaction on the
aggregation of -syn. In the presence of 5% of S87A/Ser(P)-129
(mimicking physiological conditions), we did not observe any
significant differences in the fibrillation of S87A. However, in
the presence of 20% S87A/Ser(P)-129, we observed significant
inhibition of S87A-syn fibrillation as discerned byTEM,ThT,
and SEC (Fig. 6 and supplemental Fig. 9). The aggregation of
S87A containing 20%of S87A/Ser(P)-129-synwas reduced by
85% after 48 h, 80% after 72 h, and 40% after 96 h of aggrega-
tion, whereas S87A containing 5% of S87A/Ser(P)-129 -syn
aggregated to similar level as S87A at all time points. These
findings suggest that inhibition of S87A aggregation by S87A/
Ser(P)-129 is concentration-dependent.
DISCUSSION
Phosphorylation of -syn at Ser-129 has been implicated in
the pathogenesis of PD and related synucleinopathies. How-
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ever, the exactmechanisms bywhich phosphorylationmodifies
the physiological and pathogenic properties of -syn in vivo
remain unknown. To understand the structural basis underly-
ing the effect of phosphorylation on the oligomerization and
fibrillation properties of -syn, we probed the effect of phos-
phorylation at Ser-129 on the conformational and dynamic
properties of monomeric -syn.
Phosphorylation at Ser-129 Disrupts Transient Long-range
Interactions in Monomeric -Syn—Previous studies demon-
strated that monomeric -syn assumes conformations that are
stabilized by long-range interactions and act to inhibit oli-
gomerization and aggregation (17, 33). Polyamine binding and
temperature increase, conditions that induce aggregation in
vitro, release this inherent tertiary structure (17). NMR spec-
troscopy also showed that high concentrations of chemical
denaturants disrupt the autoinhibitory conformations of
monomeric -syn, leading to an extended conformation (Fig.
2A). Here we investigated the effect of phosphorylation on the
stabilizing interactions of -syn. Hydrodynamic radii deter-
mined by NMR spectroscopy demonstrated that phosphoryla-
tion of -syn at Ser-129 strongly increased the hydrodynamic
radius of -syn (Fig. 2A). In addition, paramagnetic relaxation
enhancement of amide protons and chemical shifts showed
that long-range interactions were disrupted upon phosphoryl-
ation at Ser-129 (Fig. 2). Thus, phosphorylation strongly per-
turbs the ensemble of conformations populated by monomeric
-syn in solution. These perturbations may influence both its
pathogenic behavior as well as any physiological function of
-syn.
Ser-129 is located outside the region of -syn that is known
to modulate its interaction with membranes. Therefore, phos-
phorylation at these residues is not expected to significantly
disrupt -syn membrane interactions. Phosphorylation at Ser-
129 did not prevent the binding of -syn to liposomes nor did it
interfere with the formation of helical structure upon binding,
as indicated by the CD data (Fig. 3). Furthermore, the precise
conformation of the protein in its micelle-bound state is also
essentially unaltered by Ser-129 phosphorylation, with NMR
chemical shift changes restricted to the immediate vicinity of
the phosphorylation site within the acidic C-terminal tail and
not extending into the helical lipid binding domain. This indi-
cates that any influence of Ser-129 phosphorylation on the nor-
mal function of-syn, which is believed to be associatedwith its
membrane-bound conformation, is likely to bemediated by the
effects of the modification on protein-protein interactions
involving the C-terminal tail.
S129E/D Do Not Reproduce the Structural Consequences of
Phosphorylation at Ser-129—Although phosphorylation-mim-
icking mutations (S3E and S3D) are commonly used to
probe the structural and functional consequences of protein
phosphorylation, a direct comparison between the phosphoryl-
ation mimics and the corresponding phosphorylated form of
the protein is rarely investigated. Our in vitro studies demon-
strate that the phosphomimics S129E and S129D do not repro-
duce the effect of phosphorylation on the structural and aggre-
gation properties of -syn in vitro. Mutation of Ser-129 into
Asp or Glu did not lead to an extended conformation of mono-
meric-syn (Fig. 2A and 7).Only the conformation anddynam-
ics of residues close to the site of mutation were influenced,
indicating that mutation of Ser or Thr residues to Asp or Glu
cannot fully mimic the effect of phosphorylation on the struc-
ture and dynamics of -syn and potentially other intrinsically
disordered proteins. Together, these findings highlight the crit-
ical importance of the increased negative charge and/or bulki-
ness of the phosphate group relative to the carboxylate of Glu
and Asp in mediating the structural and functional conse-
quences of phosphorylation. Several studies have reported that
protein-protein interactions mediated by phosphoserines are
abolished when serine is replaced by glutamate. In some of
these studies it was shown that the bulkiness, steric hindrance
(34), or conformational changes (35) induced by the phosphate
group, rather than its negative charge, is responsible for the
observed effects of phosphorylation. On this basis, one can
speculate that phosphorylation of -syn may constitute an
important and specific regulator of -syn aggregation and
interactions with other proteins. These observations have
important implications for use of phosphomimics to elucidate
the role of phosphorylation in modulating biological processes
in vivo and underscore the importance of exercising caution
when interpreting results obtained using phospho-mimicking
mutants.
Mechanistic and Therapeutic Implications for PD—A
detailed molecular understanding of the functional conse-
quences of phosphorylation may reveal new insight into the
normal biology of -syn and the mechanisms by which it con-
tributes to neurodegeneration in PD and related disorders. The
first attempt to address the effect of phosphorylation on -syn
aggregation and toxicity was carried out by Feany and
co-worker (7) in aDrosophilamodel of PD overexpressingWT,
S129D, or S129A. Interestingly, the aggregation properties of
the phosphomimics (S129D and S129E) and WT -syn in vivo
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(Drosophila) bears striking resemblance towhat we observed in
vitro, withWT and S129E exhibiting the same number of inclu-
sion, whereas S129A formsmore (4) aggregates thanWT and
S129E (Fig. 4A). The S129D mutant showed enhanced toxicity
and reduced levels of -syn inclusions, whereas expression of
the S129A mutant suppressed dopaminergic cell loss and
increased the amount of-syn aggregates formed relative to the
WT or S129D mutant. One possible explanation for these
observations is that Ser(P)-129 may influence the formation
and accumulation of toxic oligomeric species of -syn rather
than of mature fibrils, which may in fact be protective. How-
ever, our in vitro studies are not entirely consistent with such a
hypothesis, since we observe that Ser-129 phosphorylation
inhibits bothmature fibril formation and also the conversion of
monomeric -syn to oligomeric species.
In addition to modulating the oligomerization and fibrillo-
genesis of-syn, phosphorylationmay be involved in regulating
its physiological properties by modulating its interactions with
other neuronal proteins and/or synaptic vesicles and phospho-
lipids. For example, -syn interacts with the microtubule asso-
ciated protein tau and stimulates tau phosphorylation (36) and
fibrillogenesis (37) both in vitro and in vivo. The tau binding site
was mapped to the C-terminal region (amino acids 87–140) of
-syn. Phosphorylation at Ser-129, but not Tyr-125 was also
reported to reduce the rate of -syn transport (38). Together,
these findings suggest that reversible phosphorylation within
the C-terminal region (Tyr-125 or Ser-129) may be involved in
regulating the association/dissociation with tau and other neu-
ronal proteins (e.g. tau, synphilin (39), phospholipaseD (31, 40),
14–3-3 (41), metals (3), and lipids. Phosphorylation within the
C-terminal region (Ser-129 or Tyr-125) or the incorporation of
phosphorylation mimicking mutations at these residues also
reportedly reduces membrane binding and blocks -syn-medi-
ate inhibition of phospholipase D2 (30, 31, 40), an enzyme
involved in the hydrolysis of phosphatidylcholine and vesicular
trafficking. Although our results demonstrate that Ser(P)-129
-syn is capable of binding to membranes in an apparently
unperturbed conformation (compared with the WT protein),
we have not measured the effects of phosphorylation on mem-
brane affinity, which may indeed be reduced.
Does Phosphorylation of -Syn Occur before or after LB
Formation?—Our findings that monophosphorylated -syn is
capable of forming ThT positive fibril-like aggregates, albeit
after longer incubations, could explain the presence of Ser(P)-
129 -syn within LBs. The morphology of the fibrils formed by
Ser(P)-129 is distinct from those formed by the unphosphoryl-
ated protein (supplemental Fig. 8); however, the pathogenic
consequences of this difference in structure or morphology has
not been investigated. Further studies are required to deter-
mine the molecular and cellular determinants that influence
the aggregation of phosphorylated -syn and whether phos-
phorylation precedes aggregation or occurs after fibrillation
and LB formation. Recent studies have shown that Ser(P)-
129 -syn accumulations colocalize with several kinases
known to phosphorylate -syn at this residue, including CK2
(42) and GRK5 (43) in LBs. These findings combined with
the fact that the C-terminal region containing Ser-129
remains exposed in the aggregated forms (protofibrils and
fibrils) of -syn support the hypothesis that phosphorylation
of -syn could also occur within LBs and is not a prerequisite
for -syn fibrillation and LB formation in PD.
Together, our findings suggest that phosphorylation may
constitute an important regulator of-syn aggregation and tox-
icity. Thus, the identification of the kinases and phosphatases
involved in regulating -syn phosphorylation could result in new
viable targets for small molecule-based therapeutic strategies for
PDandrelatedsynucleinopathies. Several kinaseshaveemergedas
viable therapeutic targets for neurodegenerative diseases, includ-
ingAlzheimer disease (44), and are likely to be the focus of intense
efforts because of the wealth of knowledge and expertise on the
development of kinase inhibitors.
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